Browse Eyewear industry topic

Joint ventures subtopic

Articles 1-19 out of 19 article(s) Title Author Type Date Words Akorn-Strides, LLC Announces FDA Approvals for Sterile Vancomycin HCl USP, 500 mg/Vial; 1 g/Vial and Sterile Vancomycin HCl USP, 5 g/Vial Pharmacy Bulk Package. Dec 31, 2008 925 Akorn-Strides, LLC Announces FDA Approval for Pamidronate Disodium Injection, 3 mg/mL and 9 mg/mL. Nov 3, 2008 859 United States: Bausch & Lomb and 20/10 Perfect Vision to form joint venture. Sep 11, 2008 162 Bausch & Lomb and 20/10 Perfect Vision Intend to Form Refractive Surgery Joint Venture. Company overview Sep 8, 2008 458 Akorn-Strides, LLC Announces FDA Approvals for Dexamethasone Sodium Phosphate Injection USP, 4 mg (base)/mL and Dexamethasone Sodium Phosphate Injection USP, 10 mg (base)/mL. Sep 2, 2008 880 Akorn-Strides, LLC Announces FDA Approvals for Famotidine Injection USP, 20 mg/2mL Single-Dose Vials and Famotidine Injection USP, 40 mg/4mL & 200 mg/20 mL Multiple-Dose Vials. Jun 26, 2008 868 Akorn-Strides, LLC Announces FDA Approval for Rifampin for Injection USP, 600 mg/Vial. May 23, 2008 852 Akorn-Strides, LLC Announces FDA Approval for Flumazenil Injection USP, 0.1 mg/mL - 5mL and 10 mL Multiple Dose Vials. May 14, 2008 891 Akorn-Strides, LLC Announces FDA Approvals for Ondansetron Injection USP, 4 mg/2mL Single Dose Vials and Ondansetron Injection USP, 40 mg/20mL Multiple Dose Vials. Apr 24, 2008 849 Akorn-Strides, LLC Announces FDA Approval for Fosphenytoin Sodium Injection USP, 100 mg/2mL and 500 mg/10mL. Mar 19, 2008 849 Akorn-Strides, LLC Announces FDA Approval for Tobramycin Injection USP, 80 mg/2mL and 1.2 grams/30mL. Mar 11, 2008 843 Akorn-Strides, LLC Announces its First ANDA Approval For Keterolac Tromethamine Injection USP, 15 mg/mL and 30 mg/mL. Jul 17, 2007 863 Akorn, Inc. and Strides Arcolab Limited Agree to Expand the Akorn-Strides, LLC Joint Venture Product Pipeline to Twenty-Nine ANDA's. Dec 6, 2006 922 Akorn-Strides, LLC Announces First ANDA Submission for a Lyophilized Injectable Drug Product. Apr 21, 2006 668 Lantis Eyewear Terminates Agreements With Eyecare Products PLC and Groupe L'Amy. Sep 22, 1998 309 Cooper Cos. Unit and Humphrey Instruments form marketing partnership. Jan 6, 1997 244 CooperVision Inc. and EyeSys Technologies Inc. collaborate on marketing partnership. Nov 21, 1996 330 QLT PhotoTherapeutics - Light-Activated Drug May Offer New Treatment for Leading Cause of Blindness Among Elderly. Apr 23, 1996 641 Sunglass Hut International signs letter of intent to operate joint venture in Southeast Asia. Feb 27, 1996 391